Lymphoblastic Leukemia (all) Molecular Study of Minimal Residual Disease (mrd) in Adult Acute Improved Risk Classification for Risk-specific Therapy Based on The
暂无分享,去创建一个
T. Barbui | A. Bosi | A. Gallamini | N. Odo | G. Rossi | A. Cortelezzi | F. Ciceri | R. Iyer | M. Kirby-Allen | J. Casella | R. Bassan | O. Spinelli | T. Intermesoli | E. Pogliani | M. Bernardi | G. Gianfaldoni | C. Romani | A. Scattolin | E. Oldani | M. Tosi | E. Borlenghi | E. Terruzzi | P. Fabris | V. Cassibba | D. Mattei | G. Lambertenghi‐Deliliers | E. Bona | Alessandro Rambaldi | Barbara Peruta | A. Rambaldi | Elliott Vichinsky | K. Mckie | Miguel R. Abboud | Tiziano Barbui | Carole Paley | Nancy Olivieri | Ofelia A. Alvarez | Margaret T. Lee | Abdullah Kutlar | Beatrice Gee | Gerald M. Woods | Thomas Coates | Winfred Wang | Janet L. Kwiatkowski | Fabio Ciceri | Julio C. Barredo | Robert J. Adams | Thomas V. Adamkiewicz | Di Eros | Claudio Bona | Romani | Giorgio Cassibba | Agostino Lambertenghi-Deliliers | Alberto Cortelezzi | Giacomo Bosi | Giuseppe Gianfaldoni | Erika Rossi | Enrico M Borlenghi | Elisabetta Pogliani | Pietro Terruzzi | Vincenzo Renato Fabris | Orietta Bassan | Elena Spinelli | Tamara Oldani | Manuela Intermesoli | Barbara Tosi | Peruta | Virgil Mckie